Poole S, Walker D, Gaines Das R E, Gallimore J R, Pepys M B
Division of Endocrinology, National Institute for Biological Standards and Control, Potters Bar, Herts, UK.
J Immunol Methods. 1998 May 1;214(1-2):1-10. doi: 10.1016/s0022-1759(98)00057-x.
An ampouled preparation of acute phase serum rich in serum amyloid A protein (SAA) was evaluated in seven laboratories in six countries for its suitability to serve as the international standard for immunoassay of SAA. A variety of different immunoassays were used. On the basis of the results reported here and with the authorization of the Expert Committee on Biological Standardization of the World Health Organization (WHO) this preparation (coded 92/680) was established as the first international standard of SAA.
一种富含血清淀粉样蛋白A（SAA）的急性期血清安瓿制剂在六个国家的七个实验室进行了评估，以确定其是否适合作为SAA免疫测定的国际标准。使用了多种不同的免疫测定方法。根据此处报告的结果并经世界卫生组织（WHO）生物标准化专家委员会批准，该制剂（编码92/680）被确立为首个SAA国际标准。
